A new synthetic strategy for pyrazolo1,5-d1,2,4triazin-7(6H)-ones 4 through intramolecular cyclization of alkyl 2-(4-nitro-1H-pyrazol-3-yl)methylene)hydrazine-1-carboxylates 3 is described, allowing us to selectively modify the N-substituent in 3-position. The reduction in nitro compounds 4 with tin(II) chloride leads to amines 5, and their acetylation leads to acetamides 6. Via alkylation of 4 with bromoacetic acid alkyl esters and 2-chloro-5-(chloromethyl)pyridine, and the subsequent reduction in alkylated nitro compounds 7, the corresponding amines 8 and amides 9 were accessible in very good yields. The molecular structure of ethyl 2-(2-morpholino-3-nitro-7-oxopyrazolo1,5-d1,2,4triazin-6(7H)-yl)acetate (7b) was confirmed by single-crystal X-Ray diffraction analysis. Antibacterial and cytotoxic properties were evaluated for 61 synthesized compounds.
Building similarity graph...
Analyzing shared references across papers
Loading...
Viktor A. Zapol’skii
Clausthal University of Technology
D. Castillo
Helmholtz Centre for Infection Research
Brigitte Pawletta
Helmholtz Centre for Infection Research
Molecules
Helmholtz Centre for Infection Research
Clausthal University of Technology
Building similarity graph...
Analyzing shared references across papers
Loading...
Zapol’skii et al. (Thu,) studied this question.
synapsesocial.com/papers/68d464ff31b076d99fa64cec — DOI: https://doi.org/10.3390/molecules30183792
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: